External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort
Karen Bolhuis(The Netherlands Cancer Institute), Jeanine M.L. Roodhart(University Medical Center Utrecht), G. Emerens Wensink(Utrecht University), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers), Marloes A.G. Elferink(Netherlands Comprehensive Cancer Organisation), Cornelis J.A. Punt(Utrecht University), Geraldine R. Vink(Utrecht University), Miriam Koopman(Utrecht University), Remond J.A. Fijneman(Dutch Cancer Society), Inne H.M. Borel Rinkes(Utrecht University), Willemieke P.M. Dijksterhuis(Netherlands Comprehensive Cancer Organisation), Sjoerd G. Elias(Utrecht University), Marinde J. G. Bond(Utrecht University), Jeroen Hagendoorn(Utrecht University), Onno Kranenburg(Utrecht University)
Cited by 11
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2010|1k
From tumour heterogeneity to advances in precision treatment of colorectal cancer
|Nature Reviews Clinical Oncology|2016|692